Dexamethasone Swish and Spit for Herpangina: Not Recommended
Do not use dexamethasone swish-and-spit for herpangina in adults. This is a self-limited viral infection caused by enteroviruses (primarily Coxsackievirus-A) that resolves spontaneously in 4-6 days with supportive care only 1.
Why Steroids Are Contraindicated
Active Viral Infection Concerns
The FDA label explicitly warns that corticosteroids increase susceptibility to viral infections and may mask signs of current infection 2. In the context of an active enteroviral infection like herpangina, using immunosuppressive therapy—even topically—is counterproductive and potentially harmful.
Risk-Benefit Analysis
- No mortality/morbidity benefit: Herpangina has excellent prognosis without intervention 1
- Potential harm: Systemic absorption occurs even with "swish and spit" technique, as demonstrated by documented cases of adrenal suppression from dexamethasone mouthwash 3
- Viral exacerbation risk: The FDA specifically cautions about serious or fatal courses of viral infections in patients on corticosteroids 2
Appropriate Management of Herpangina
Treatment should be symptomatic only 1:
- Topical oral sprays with antiviral properties (for symptom relief, not cure)
- Analgesics for pain control
- Hydration support
- Reassurance about the 4-6 day self-limited course
When Dexamethasone Swish-and-Spit IS Appropriate
The ESMO guidelines 4 and supporting research 5, 6, 7 support dexamethasone mouthwash (0.1 mg/ml) specifically for:
- mTOR inhibitor-associated stomatitis (cancer therapy complication)
- Oral lichen planus (chronic inflammatory condition)
- Chemotherapy/radiation-induced mucositis
These are fundamentally different pathophysiologic processes involving inflammatory injury rather than active viral replication.
Critical Pitfall to Avoid
Do not confuse herpangina (enteroviral pharyngitis with characteristic posterior pharyngeal vesicles) with other oral mucosal conditions. The presence of "herp-" in the name does not indicate HSV infection, and the inflammatory stomatitis protocols used in oncology patients 4 are not applicable to acute infectious diseases.
Even in HSV encephalitis—a far more severe HSV infection—adjunct dexamethasone showed no benefit 8, reinforcing that steroids do not improve outcomes in active viral conditions.